TGFB1 and cancer: It has been shown to inhibit TGF‐β1 and TGF‐β2 cytokine‐stimulated cell growth and migration, and to reduce the effect of these cytokines on decreasing susceptibility of malignant tumor cells to the immune system, both in vivo and in vitro.